Dr. Chuanhui Cao | Infections | Best Researcher Award

Nanfang Hospital, Southern Medical University | China.

Author Profile

🎓Education

Dr. Cao holds a strong educational background in medical and molecular sciences, specializing in oncology. His academic foundation has equipped him to explore the complexities of liver cancer at the molecular level, bridging clinical applications and innovative research.

💼Professional Experience

Dr. Cao serves as an Associate Professor and Attending Physician. With a supervisory role, he guides doctoral and postdoctoral scholars, nurturing the next generation of researchers. His expertise extends into translational oncology, focusing on treatment resistance and tumor biology.

🔬Technical Skills

Molecular Biology Techniques: Single-cell transcriptomics, gene editing, and RNA sequencing

Clinical Oncology: Precision radiotherapy, immune checkpoint inhibitor research

📚Academic Contributions

Standing Committee Member, Radiation Oncology Professional Committee, Guangdong Hospital Association

Standing Committee Member, Tumor Diagnosis and Treatment Technology Transformation Professional Committee, Guangdong Medical Education Association

Member, Precision Radiotherapy Branch, Guangdong Society of Precision Medicine.

🔬Research Interests

Dr. Cao is dedicated to understanding the molecular mechanisms underlying liver cancer, with a focus on treatment resistance, tumor microenvironment, and immunotherapy enhancements.

🏆Awards and Honors

Guangzhou “Pearl River Science and Technology Rising Star” (2019)

First Prize, Guangdong Provincial Natural Science Award

🔬Funded Research Projects

Mechanisms of PFOS-induced differentiation of stem-like CD8+ T cells, promoting liver cancer progression (2025–2028)

AXIN1 mutation and radiotherapy efficacy (2021–2024)

Long non-coding RNA AP000695.4 in liver cancer progression

📘Teaching Experience

As a doctoral and postdoctoral mentor, Dr. Cao has contributed significantly to academic training, guiding research projects and facilitating translational research in liver cancer.

📑Notable Publications

“Antiangiogenic Treatment Facilitates the Abscopal Effect of Radiation Therapy Combined With Anti-PD-1 in Hepatocellular Carcinoma”

Authors: Sheng, H.; Luo, Y.; Zhong, L.; … Sun, J.; Cao, C.
Publication Year: 2025
Journal: International Journal of Radiation Oncology Biology Physics

“Diethylhexyl phthalate induces immune dysregulation and is an environmental immune disruptor”

Authors: Linghu, D.; Zhu, Z.; Zhang, D.; … Sun, J.; Cao, C.
Publication Year: 2024
Journal: Journal of Hazardous Materials

“Polystyrene microplastics aggravate radiation-induced intestinal injury in mice”

Authors: Chen, Y.; Zeng, Q.; Luo, Y.; … Sun, J.; Cao, C.
Publication Year: 2024
Journal: Ecotoxicology and Environmental Safety

“Single-cell transcriptomics reveal the microenvironment landscape of perfluorooctane sulfonate-induced liver injury in female mice”

Authors: He, X.; Sun, Z.; Sun, J.; … Song, M.; Cao, C.
Publication Year: 2024
Journal: Science of the Total Environment

“Overexpression of ubiquitin-conjugating enzyme 2T induces radiotherapy resistance in hepatocellular carcinoma by enriching regulatory T cells in the tumor microenvironment | UBE2T 通过调节性 T 细胞诱导肝细胞癌的放疗抵抗”

Authors: He, X.; Xiong, S.; Zhu, Z.; … Cao, C.; Wang, H.
Publication Year: 2024
Journal: Nan Fang Yi Ke Da Xue Xue Bao / Journal of Southern Medical University